56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
基本信息
- 批准号:10752090
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-10 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAcute DiseaseAddressAutoimmunityAwardAwarenessBasic ScienceBig DataBiologyChronic DiseaseClinicClinicalCoffeeCommunitiesDevelopmentDiseaseDisparity populationDoctor of PhilosophyEducational workshopEquilibriumEquityEthnic OriginFosteringFunctional disorderFundingFutureGenderGeographyGoalsGovernmentHealthHost DefenseImmune responseImmune systemImmunityImmunologyIndustryInflammationInformation DisseminationInstructionLearningLeukocytesMalignant NeoplasmsMedicineMentorsNatural ImmunityOralPublic HealthRaceResearchResearch PersonnelRoleScientific SocietiesScientistSeminalSiteSocietiesTexasTranslatingTranslationsTravelUnderrepresented PopulationsUniversitiesWomanadaptive immunitycancer immunotherapycareercareer developmentdesigndiversity and inclusionequity, diversity, and inclusionexpectationexperienceforgingfrontierhuman diseaseinnovationinsightinterestinternational partnershipmeetingsnext generationnovelnovel therapeutic interventionpathogenic microbepathogenic viruspostersprogramssuccesssymposiumtechnological innovation
项目摘要
ABSTRACT
This proposal is to request support for the 56th Annual Meeting of the Society for Leukocyte Biology
entitled: “The Future of Immunology: New Solutions to Old Problems”. The meeting will be held September 27 –
30, 2023, at the University of Georgia Conference Center in Athens, GA. Funds derived from this proposal will
be distributed in the form of travel awards that will provide much needed assistance to young investigators and
trainees. The Organizers of the 56th annual meeting are Peter Keyel, Ph.D. (Texas Tech University) and Balázs
Rada, Ph.D. (University of Georgia).
SLB is the leading scientific society with a focus on leukocytes and their roles in the pathophysiology of
acute and chronic diseases. No other scientific meeting regarding study of the immune system focuses on the
leukocyte with the breadth and depth of SLB, so the annual meetings sponsored by SLB fill this void. Therefore,
SLB is the premier society in the field of leukocyte biology, and convenes annually to promote scientific exchange
among researchers and support the career development of trainees and junior investigators. Funds derived from
this proposal will be distributed in the form of travel awards that will provide much needed assistance to facilitate
the ability of young investigators and trainees to attend. The essential goals of the annual meeting include: 1)
advancing original research and related scientific endeavors in the field of leukocyte biology and host defense,
2) promoting the career development of junior and new investigators interested in leukocyte biology, 3)
disseminating information about the field to the wider scientific and lay audience, and 4) encouraging the
translation of basic research in leukocyte biology to applications in the clinic. These goals will be achieved
through three Aims: Aim 1: To provide an innovative and scientifically progressive program, in a collegial forum,
to address the latest developments in leukocyte biology. The agenda will include a total of 4 Plenary Sessions
and 8 Concurrent Sessions with a total of 19 invited speakers. Aim 2: To provide an opportunity for new
investigators and trainees to interact closely with established scientists. A significant innovation for recent
iterations of the annual meeting is the SLB-SCHOOL (Society for Leukocyte Biology-Symposium for Career
development and Hands-On Opportunity to Learn) which offers trainees a full day instructional workshop
covering topics related to leukocyte biology research. The expectation is that enrollees will gain practical insight
into this topic and more actively participate with experts in the field. Aim 3: To promote diversity and inclusion in
the field of leukocyte biology by cultivating the participation of women, underrepresented groups and
disadvantaged individuals. The Diversity, Equity and Inclusion (DEI) committee will sponsor workshops and
awards to encourage the participation of women and scientists from underrepresented groups. In sum, the 2023
annual meeting of SLB is purposefully designed to enhance awareness of the influence of leukocyte biology in
health and disease and inspire young investigators.
抽象的
该建议是要求对白细胞生物学协会第56届年会的支持
题为:“免疫学的未来:旧问题的新解决方案”。会议将于9月27日举行 -
2023年30日,在佐治亚州雅典的佐治亚大学会议中心。该提议得出的资金将
以旅行奖的形式分发,将为年轻的调查人员和
学员。第56届年会的组织者是Peter Keyel博士。 (德克萨斯理工大学)和Balázs
Rada,博士(佐治亚大学)。
SLB是领先的科学学会,重点是白细胞及其在病理生理学中的作用
急性和慢性疾病。关于免疫系统研究的其他科学会议都没有关注
白细胞具有SLB的宽度和深度,因此SLB赞助的年度会议填补了这一空白。所以,
SLB是白细胞生物学领域的主要社会,每年召集以促进科学交流
在研究人员中,支持受训者和初级研究人员的职业发展。来自
该建议将以旅行奖的形式分发,该奖项将提供急需的帮助以促进
年轻的调查员和学员参加的能力。年会的基本目标包括:1)
推进白细胞生物学和宿主防御领域的原始研究和相关科学努力,
2)促进对白细胞生物学感兴趣的初级和新调查人员的职业发展,3)
向更广泛的科学和外行听众传播有关该领域的信息,以及4)鼓励
将白细胞生物学基础研究翻译成诊所的应用。这些目标将被实现
通过三个目标:目标1:在一个大学论坛上提供创新和科学进步的计划,
解决白细胞生物学的最新发展。议程将包括4个全体会议
和8次并发会议,共有19名受邀演讲者。目标2:为新的机会提供机会
调查人员和学员与知名科学家紧密互动。最近的重大创新
年会的迭代是SLB学校(白细胞生物学学会职业生物学学会
开发和动手学习的机会)为学员提供全天教学研讨会
涵盖与白细胞生物学研究有关的主题。期望注册将获得实用的见解
进入这个主题,并更积极地与该领域的专家一起参与。目标3:促进多样性和包容性
白细胞生物学领域通过培养妇女的参与,代表性不足的群体和
不利的人。多样性,公平与包容(DEI)委员会将赞助讲习班,并
奖励鼓励妇女和科学家的参与,来自代表性不足的群体。总之,2023年
SLB的年度会议旨在提高人们对白细胞生物学影响的认识
健康与疾病,并激发年轻的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG THOMAS LEFORT其他文献
CRAIG THOMAS LEFORT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG THOMAS LEFORT', 18)}}的其他基金
Selective Modulation of Neutrophils in Critical Illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
10551956 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
9750019 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
A murine model of Pseudomonas aeruginosa pneumonia secondary to hemorrhagic shock
失血性休克继发铜绿假单胞菌肺炎小鼠模型
- 批准号:
9294349 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
9382234 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
10220991 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
相似国自然基金
影像组学用于急性病毒性肺炎鉴别诊断的生物学机制探究
- 批准号:82172029
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
影像组学用于急性病毒性肺炎鉴别诊断的生物学机制探究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
胆碱能抗炎通路调节巨噬细胞M1/M2极化在CVB3诱导的急性病毒性心肌炎中的作用及机制研究
- 批准号:81870281
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
急性病毒感染中转录因子Tbet对TFH应答的调控及机制研究
- 批准号:31700774
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
调控巨噬细胞极化的microRNA分子鉴定及其在CVB3诱导的急性病毒性心肌炎中的作用
- 批准号:81472017
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Targeting microglial cell iron-handling in Alzheimer’s Disease
靶向阿尔茨海默病中的小胶质细胞铁处理
- 批准号:
10603992 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to Therapy
慢性移植物抗宿主病生物标志物:治疗耐药性的预测
- 批准号:
10751970 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Mentored research in the intersection of kidney and cardiovascular disease
肾脏和心血管疾病交叉领域的指导研究
- 批准号:
10795588 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
2022 Biology of Acute Respiratory Infection GRC / GRS
2022 急性呼吸道感染生物学 GRC / GRS
- 批准号:
10388659 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别: